Promising PANDAS painkiller trial fizzles out
NCT ID NCT04015596
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study aimed to see if naproxen sodium, a common anti-inflammatory drug, could reduce obsessive-compulsive symptoms in children with PANDAS, a condition linked to strep infections. The trial planned to enroll children aged 6 to 15 with new-onset OCD, but was terminated early after only 2 participants. No results are available due to the small size.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.